No legislative signals found for $AKAM, but it appears in 1 congressional trade filing.
⚠ Representative Shreve bought $15,001 - $50,000 in AMGN on February 24, 2025 — 8 days before the EPIC Act of 2025 (S832) was introduced, which proposes to extend market exclusivity for small-molecule drugs.